22q11.2 DELETION SYNDROME: ALGORITHM FOR THE EARLY DIAGNOSIS AND TREATMENT
Leyla S. Namazova-Baranova,
Olga V. Ginter,
Tatyana A. Polunina,
Irina V. Davydova,
Kirill V. Savostyanov,
Alexandr A. Pushkov,
Natalya V. Jourkova,
Tatyana Y. Mospan https://doi.org/10.15690/vsp.v16i5.1803
Abstract
Chromosomal diseases, in particular microdeletions, determine the child's condition as well as the prognosis for a disease even at birth. With timely identified chromosomal abnormalities, we can diagnose not only obvious but also hidden disorders in the organs and their systems and timely correct the child's treatment at an early age. The algorithm for diagnosis of chromosomal abnormalities in children is an important component of a modern pediatric practice. It allows to increase the effectiveness of chromosomal pathology treatment.
About the Authors
Leyla S. Namazova-Baranova
National Medical Research Center of Children’s Health;
Pirogov Russian National Research Medical University
Russian Federation
Disclosure of interest: receiving research grants from pharmaceutical companies Pierre Fabre, Genzyme Europe B.V., AstraZeneca Pharmaceuticals, Gilead / PRA Pharmaceutical Research Associates CIS, Teva Branded Pharmaceutical Products R&D, Inc / PPD Development (Smolensk), Stallergenes S.A. / Quintiles GeismbH (Austria)
Russian Federation
Disclosure of interest: receiving research grants from pharmaceutical companies Pierre Fabre, Genzyme Europe B.V., AstraZeneca Pharmaceuticals, Gilead / PRA Pharmaceutical Research Associates CIS, Teva Branded Pharmaceutical Products R&D, Inc / PPD Development (Smolensk), Stallergenes S.A. / Quintiles GeismbH (Austria)
Olga V. Ginter
National Medical Research Center of Children’s Health
Russian Federation
Russian Federation
Tatyana A. Polunina
National Medical Research Center of Children’s Health
Russian Federation
Russian Federation
Irina V. Davydova
National Medical Research Center of Children’s Health;
Pirogov Russian National Research Medical University
Russian Federation
Disclosure of interest: cooperates with Abbvie
Russian Federation
Disclosure of interest: cooperates with Abbvie
Kirill V. Savostyanov
National Medical Research Center of Children’s Health
Russian Federation
Russian Federation
Alexandr A. Pushkov
National Medical Research Center of Children’s Health
Russian Federation
Russian Federation
Natalya V. Jourkova
National Medical Research Center of Children’s Health
Russian Federation
Russian Federation
Tatyana Y. Mospan
National Medical Research Center of Children’s Health
Russian Federation
Russian Federation
References
1. Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332–339.e1. doi: 10.1016/j.jpeds.2011.02.039.
2. Delio M, Guo T, McDonald-McGinn DM, et al. Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J Hum Genet. 2013;92(3):439–447. doi: 10.1016/j.ajhg.2013.01.018.
3. Scambler PJ. The 22q11 deletion syndrome. Hum Mol Genet. 2000;9(16):2421–2426. doi: 10.1093/hmg/9.16.2421.
4. Козлова Ю.О. Разработка технологии пре- и постнатальной диагностики группы синдромов, обусловленных микроделецией 22q11.2: Автореф. дис. … канд. мед. наук. — М.; 2014. — 26 с. [Kozlova YuO. Razrabotka tekhnologii pre- i postnatal’noi diagnostiki gruppy sindromov, obuslovlennykh mikrodeletsiei 22q11.2. [dissertation abstract] Moscow; 2014. 26 p. (In Russ).]
5. Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med. 2001;3(1):14–18. doi: 10.109700125817-200101000-00004.
6. Beauchesne LM, Warnes CA, Connolly HM, et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005;45(4): 595–598. doi: 10.1016/j.jacc.2004.10.056.
7. Keyte AL, Alonzo-Johnsen M, Hutson MR. Evolutionary and developmental origins of the cardiac neural crest: building a divided outflow tract. Birth Defects Res C Embryo Today. 2014;102(3): 309–323. doi: 10.1002/bdrc.21076.
8. McElhinney DB, McDonald-McGinn D, Zackai EH, Goldmuntz E. Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics. 2001;108(6):e104. doi: 10.1542/peds.108.6.e104.
9. Федеральные клинические рекомендации по диагностике и лечению синдрома делеции 22-й хромосомы. — М.: Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева; 2014. — 12 с. [Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu sindroma deletsii 22-i khromosomy. Moscow: Federal’nyi nauchnoklinicheskii tsentr detskoi gematologii, onkologii i immunologii im. Dmitriya Rogacheva; 2014. 12 p. (In Russ).]
10. Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res. 2005;63(6):294–299. doi: 10.1159/000086745.
11. Cheung EN, George SR, Costain GA, et al. Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome. Clin Endocrinol (Oxf). 2014;81(2):190–196. doi: 10.1111/cen.12466.
12. Taylor SC, Morris G, Wilson D, et al. Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child. 2003;88(6):520–522. doi: 10.1136/adc.88.6.520.
13. Piliero LM, Sanford AN, McDonald-McGinn DM, et al. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood. 2004;103(3):1020–11025. doi: 10.1182/blood-2003-08-2824.
14. Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics. 2009;12(5):e871–e877. doi:10.1542/peds.2008-3400.
15. Zemble R, Luning Prak E, McDonald K, et al. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol. 2010;136(3):409–418. doi: 10.1016/j.clim.2010.04.011.
16. Greenhalgh KL, Aligianis IA, Bromilow G, et al. 22q11 deletion: a multisystem disorder requiring multidisciplinary input. Arch Dis Child. 2003;88(6):523–524. doi: 10.1136/adc.88.6.523.
17. Digilio MC, Pacifico C, Tieri L, et al. Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol. 1999;33(5):329–333. doi: 10.3109/ 03005369909090116.
18. Ford LC, Sulprizio SL, Rasgon BM. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients. Laryngoscope. 2000;110(3 Pt 1):362–367. doi: 10.1097/00005537-200003000-00006.
19. Schneider M, Debbane M, Bassett AS, et al. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014;171(6): 627–639. doi: 10.1176/appi.ajp.2013.13070864.
20. Green T, Gothelf D, Glaser B, et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1060–1068. doi: 10.1097/ CHI.0b013e3181b76683.
21. Glaser B, Mumme DL, Blasey C, et al. Language skills in children with velocardiofacial syndrome (deletion 22q11.2). J Pediatr. 2002;140(6):753–758. doi: 10.1067/mpd.2002.124774.
22. Gerdes M, Solot C, Wang PP, et al. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet. 1999;85(2):127–133. doi: 10.1002/(sici)1096-8628(19990716)85:23.3.co;2-6.
23. Mills L, Gosling A, Sell D. Extending the communication phenotype associated with 22q11.2 microdeletion syndrome. Int J Speech Lang Pathol. 2006;8(1):17–27. doi: 10.1080/14417040500459650.
24. Kiley-Brabeck K, Sobin C. Social skills and executive function deficits in children with the 22q11 Deletion Syndrome. Appl Neuropsychol. 2006;13(4):258–268. doi: 10.1207/ s15324826an1304_7.
25. McDonald-McGinn DM, Sullivan K. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90(1):1–18. doi: 10.1097/ MD.0b013e3182060469.
26. Forbes BJ, Binenbaum G, Edmond JC, et al. Ocular findings in the chromosome 22q11.2 deletion syndrome. J AAPOS. 2007; 11(2):179–182. doi: 10.1016/j.jaapos.2006.08.006.
Review
For citations:
Namazova-Baranova L.S., Ginter O.V., Polunina T.A., Davydova I.V., Savostyanov K.V., Pushkov A.A., Jourkova N.V., Mospan T.Y. 22q11.2 DELETION SYNDROME: ALGORITHM FOR THE EARLY DIAGNOSIS AND TREATMENT. Current Pediatrics. 2017;16(5):392-398. (In Russ.) https://doi.org/10.15690/vsp.v16i5.1803
Views:
1095
Email this article 
